...
Recombinant Feline IL-12/IL-23 p40...
HybriWell hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Equine TNF-alpha/TNFSF1A, CF...
Biology Products:... egg yolks, and it has long been theorized that ... males. However, a study from the November/December 2006 issue ... birds get their day. Providing new insight into the ... found that female house finches deposit significantly more antioxidants, ...
... way to make sense of 165-million-year-old dino tracks may be ... dinosaur footprints at the Red Gulch Dinosaur Tracksite in northern ... two legs and have similar feet, emus turn out to ... once trotted along a long-lost coastline in the Middle Jurassic. ...
... into the genome of fruit flies or Drosophila ?promises to ... function of virtually all the fly’s genes, and the method ... mice, said its Baylor College of Medicine developers in an ... “P(acman) overcomes a key limitation of currently available methods because ...
Other Biology News:Trotting with emus to walk with dinosaurs 2Trotting with emus to walk with dinosaurs 3P(acman) takes a bite out of deciphering Drosophila DNA 2(Date:12/2/2009)... Reportlinker.com announces that a new market ... ,, Drug Discovery Technologies - A ... ,, http://www.reportlinker.com/p0164246/Drug-Discovery-Technologies---A-Global-Update-of-Market-Trends--Opportunities.html ,, Drug ... element of every pharmaceutical company,s business strategy. ...
(Date:12/2/2009)... ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced ... offering, the underwriters have exercised in full their over-allotment ... is comprised of one common share and 0.4 of ... a price of US$3.00 per unit. Each whole common ...
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris ... "Company"), a global biopharmaceutical company focused on endocrine ... Food and Drug Administration (FDA) has granted Fast ... compound, perifosine (KRX-0401), for the treatment of relapsed/refractory ...
Breaking Biology Technology:Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3